LE Zenrid Tablet
By LE Zenrid
Rx
10 Tablet in a Strip

Composition
Levocetirizine(5mg)

Manufacturer - Kaizen Pharmaceuticals Pvt Ltd
C -36, Block 2, Clifton, Karachi, Pakistan.

Expires on or after
October, 2025

liver
LE Zenrid Tablet is considered safe for use in patients with liver disease. It is generally advised that no dose adjustment of LE Zenrid Tablet is needed for individuals with liver issues. This means that individuals with liver conditions can take this medication without needing to change the dosage. However, it is essential to be cautious and monitor any potential effects on the liver while using LE Zenrid Tablet. If you have concerns or experience any adverse effects, consult your healthcare provider for guidance.

kidney
LE Zenrid Tablet requires caution in patients with kidney disease. Adjustments to the dose may be necessary. Consult your doctor for guidance.

alcohol
When taking LE Zenrid Tablet, be cautious as it can lead to increased drowsiness when mixed with alcohol.

driving
When taking LE Zenrid Tablet, be cautious while driving. It may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
LE Zenrid Tablet is not recommended during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Kindly consult your healthcare provider.

breastfeeding
During breastfeeding, it is advised to be cautious when using LE Zenrid Tablet. Limited data suggests it may pass into breastmilk, potentially harming the baby. Higher doses or prolonged use can lead to drowsiness or reduce milk supply.
Habit Forming | No |
Chemical Class | Piperazine Derivative |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹28.42
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024